Skip to main navigation Skip to search Skip to main content

Extraosseous Ewing sarcoma with foci of neuroblastoma-like differentiation associated with EWSR1(Ewing sarcoma breakpoint region 1)/FLI1 translocation without prior chemotherapy

  • K. Vali
  • , V. Kokta
  • , M. Beaunoyer
  • , R. Fetni
  • , P. Teira
  • , Hervé Sartelet
  • Sainte-Justine Hospital University Center

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

Peripheral primitive neuroectodermal tumor/Ewing sarcoma and neuroblastoma are distinct malignant tumors belonging to the group of undifferentiated solid pediatric tumors. We report a case of a 14-year-old adolescent girl who presented with a right lower quadrant mass. At surgery, a mobile retroperitoneal mass was entirely removed. Histologic evaluation revealed 2 distinct components; the first, consisting of sheets of undifferentiated cells, was CD99+ and CD56-, whereas the second, consisting of multiple foci of neuropil and maturing neuroblasts, was CD99- and CD56+. Fluorescence in situ hybridization analysis revealed the presence of EWSR1/FLI1 translocation in both histologic distinct components. MYCN (myelocytomatosis viral related oncogene, neuroblastoma derived) was not amplified. The tests for t(11;22) and t(21;22) performed by reverse transcription-polymerase chain reaction were negative. The final diagnosis corresponds to an extraosseous Ewing sarcoma with foci of neuroblastoma-like differentiation. This is the first case, documented by molecular studies, in which neuroblastoma-like differentiation has been noted in primitive neuroectodermal tumor/Ewing sarcoma without prior chemotherapy.

Original languageEnglish
Pages (from-to)1772-1776
Number of pages5
JournalHuman Pathology
Volume43
Issue number10
DOIs
StatePublished - Oct 2012

Keywords

  • Ewing sarcoma
  • Neuroblastoma

Fingerprint

Dive into the research topics of 'Extraosseous Ewing sarcoma with foci of neuroblastoma-like differentiation associated with EWSR1(Ewing sarcoma breakpoint region 1)/FLI1 translocation without prior chemotherapy'. Together they form a unique fingerprint.

Cite this